Nyla Haque

I am a Clinical Trial Manager working within the Oxford Brain Health Clinical Trials Unit (OBHCTU) where I am responsible for the set-up and oversight of medical technology studies. I am currently setting up the PETRUSHKA study led by Professor Andrea Cipriani, which aims to evaluate a novel decision-making tool which will be used to aid clinicians in prescribing antidepressants. Prior to joining the OBHCTU, I was working within the Translational Neuroscience and Dementia Research Group setting up and managing multi-centre clinical trials and observational studies in Alzheimer's disease, Mild Cognitive Impairment (MCI) and healthy populations. Previous to this, I worked as a Clinical Trial Coordinator within an NHS setting. I was involved in several phase I-III clinical trials investigating novel disease modifying therapies in patients with Alzheimer’s disease. Within my time at the Neuroepidemology & Ageing Unit, Imperial College London, I gained experience of coordinating a large prospective readiness cohort study investigating risk factors of Alzheimer’s disease in healthy participants. While studying for my BSc Psychology degree, I spent my university placement year working in a neurorehabilitation service for adults who had suffered traumatic & acute brain injury.